Pregnancy and Latent Labor Biomarkers and Symptoms to Predict Cervical Dilation at Hospital Admission.
NCT ID: NCT04437576
Last Updated: 2020-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2019-09-13
2021-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim #1: Characterize IL-8 (pro-inflammatory biomarker), basal body temperature, maternal heart rate, and electrical activity of the uterus prior to spontaneous onset of labor through the onset of active labor among nulliparous women. IL-8 will be quantified weekly, daily basal body temperature, as well as continuous maternal heart rate and electrical activity of the uterus throughout the transition from late pregnancy into active labor.
Aim #2: Characterize latent labor symptoms among nulliparous women in spontaneous labor. Using Likert scale, childbirth-specific, symptom-specific PROMIS measures,45 and open-ended questions will be quantified and characterize latent labor symptoms (e.g., intensity, frequency) and identify relevant themes.
Aim #3: Characterize trajectories of labor biomarkers and latent labor symptoms across latent labor duration. A modified growth mixture modeling approach to quantify subgroup phenotypes among nulliparous women in spontaneous latent labor will be employed.
Hypothesis 3.1. There will be significant congruence between higher biomarkers (e.g., higher IL-8, more uterine electrical activity) and symptoms that are more intense and frequent.
Hypothesis 3.2. At least two classes of laboring women with distinct trajectories of change in biomarkers and symptoms can be identified and will be associated with cervical dilation at hospital admission.
Exploratory Aim: Characterize biomarkers among nulliparous women with spontaneous labor onset vs. nulliparous women requiring labor induction for post-term gestation. Weekly IL-8, daily basal body temperature, as well as continuous maternal heart rate and electrical activity of the uterus throughout the transition from late pregnancy into active labor between those whose labor begins spontaneously and those whose labors are induced for post-term gestation will be quantified.
Exploratory Hypothesis. There will be different biomarker patterns between women with spontaneous labor onset vs. those without.
The Standard descriptive and inferential statistics as well as growth mixture modeling for quantitative aims will be used. The investigators will use thematic development for qualitative aims.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Self-Obtained Ultrasound Scans for Measurement of Cervical Dilation and Effacement in Labor
NCT05038891
Cervical Length Pre-induction as a Tool to Predict Vaginal Birth
NCT02916082
Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor
NCT02975167
Labor Induction and Maternal BMI, Comparison of Different Pre-induction Cervical Ripening Methods
NCT02223949
Fetal Heart Rate Changes and Labor Neuraxial Analgesia: a Machine Learning Approach
NCT05399979
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Maternal age of at least 20 years of age.
3. Maternal age of no greater than 39 years of age.
4. Viable, term pregnancy: ≥ 37 weeks gestation at time of signing study consent.
5. Able to understand and provide an informed consent.
6. Able to understand English.
Exclusion Criteria
2. Managing complex comorbidities (e.g., preeclampsia)
3. Documented fetal congenital anomalies
4. Preterm labor and birth
5. Persistent breech fetal position at term
6. Fetal death prior to the onset of labor
7. Any indication for planned cesarean birth (e.g., placenta previa)
8. Induction of labor for medical indication (e.g., oligohydramnios)
20 Years
39 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bloomlife Technologies
UNKNOWN
Medical Research Foundation, Oregon
OTHER
OHSU School of Nursing
UNKNOWN
Oregon Health and Science University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ellen Tilden
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ellen Tilden, PhD, CNM
Role: PRINCIPAL_INVESTIGATOR
Oregon Health and Science University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
OHSU
Portland, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00020328
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.